Loading viewer...
investor_presentation
Format: PDF investor_presentation
ALS Limited presents its FY22 financial results, demonstrating achievement of its five-year strategic plan with $2 billion in revenue and $409 million in underlying EBIT. The company achieved mid-single digit organic growth, strong cash conversion exceeding 90%, and improved earnings per share by 135% since FY17.
infographic
investor_presentation
19 Pages
Tactile Medical
investor_presentation
Cleo Diagnostics
investor_presentation
Cassini Resources
Canadian Utilities Investor Presentation 2019
investor_presentationinvestor_presentation
32 Pages
Canadian Utilities Limited